A chemistry-first drug discovery biotechnology company developing an AI-enabled, automated synthesis platform that rapidly makes complex small molecules and other therapeutic compounds
A chemistry-first drug discovery biotechnology company developing an AI-enabled, automated synthesis platform that rapidly makes complex small molecules and other therapeutic compounds. It combines synthesis and screening in a direct-to-biology Design-Make-Test-Analyze workflow to explore previously inaccessible chemical space and accelerate early-stage drug discovery.